Centrex (ASX:CXM) exports its first 5,000 ton of phosphate rock to New Zealand

Marc Kennis Marc Kennis, November 21, 2022

Queensland-based phosphate rock producer Centrex (ASX:CXM) announced that it just sent its first international shipment of phosphate rock overseas. Agricultural Cooperative Ravensdown, based in New Zealand, is the recipient of this first shipment that was sent FOB from Townsville. This shipment was sold back in April as a trial shipment.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Investors were happy with the news and sent the shares 7% higher. In the last 2 months, CXM shares traded around 13.5 cents, but may head higher as the company keeps announcing good news around shipments, domestically and internationally.

Centrex is expected to partly replace phosphate rock shipments from Morocco to Australia, New Zealand and Asia. As such, Centrex will be a key contributor to reducing Australia’s dependence on overseas phosphate. This is particularly important in light of the Russian/Ukranian war that has resulted in substantial phosphate price rises.

 

Centrex

 

First product out of Centrex’s Ardmore mine was shipped in early October, but we’ll have to until the company’s quarterly statement at the end of January to see what the actual selling price was. Phosphate prices have gone up very substantially in the last year, with Morocco phosphate rock prices now above US$300/tonne. If CXM can manage to sell its product at  similar prices, we expect the share price will go a lot higher than where it is today.

Stocks Down Under subscribers can read our recent article on Centrex here.

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…